XML 18 R19.htm IDEA: XBRL DOCUMENT
v3.19.3

Cash and Marketable Securities | 9 Months Ended
--- | ---
Sep. 30, 2019
Cash and Marketable Securities [Abstract] |
Cash and Marketable Securities | Note 13. Cash and Marketable Securities Cash, money market funds and certificates of deposit with maturities of three months or less when purchased are included in Cash and cash equivalents in the accompanying condensed consolidated statements of financial position. As of September 30, 2019 and December 31, 2018, marketable securities primarily consisted of treasury bills with maturities of less than one year and are classified as available-for-sale securities. The amortized cost, fair value and gross unrealized gains and losses of our short-term investments are as follows:
|  |  |  |  | Gross |  | Gross |  |  |
|  | Amortized |  | Unrealized |  | Unrealized |  | Fair
(In millions) |  | Cost |  | Gains |  | Losses |  | Value
Available-for-sale securities, September 30, 2019 |  |  |  |  |  |  |  |  |  |  |  |
Debt securities |  | $ | 7 |  | $ | — |  | $ | — |  | $ | 7
Available-for-sale securities, December 31, 2018 |  |  |  |  |  |  |  |  |  |  |  |
Debt securities |  | $ | 9 |  | $ | — |  | $ | — |  | $ | 9
There were no unrealized losses which had been in a loss position for more than one year as of September 30, 2019 and December 31, 2018. Gains and losses on sales of investments, as determined on a specific identification basis, are included in investment income in the period they are realized. For the three and nine months ended September 30, 2019 and 2018, there were no gross realized gains or losses resulting from sales of available-for-sale securities. The table below summarizes proceeds and maturities for the periods indicated.
|  | Three Months Ended |  | Nine Months Ended
|  | September 30, |  | September 30,
(In millions) |  | 2019 |  | 2018 |  | 2019 |  | 2018
Proceeds from sale of securities |  | $ | — |  | $ | 16 |  | $ | — |  | $ | 17
Maturities of securities |  |  | 5 |  |  | 6 |  |  | 9 |  |  | 15
We periodically review our portfolio of investments to determine whether there has been an other-than-temporary decline in the value of the investments from factors such as deterioration in the financial condition of the issuer or the market(s) in which the issuer competes. There were no impairment charges due to declines in the value of these investments for the three and nine months ended September 30, 2019 and 2018.

X
- Definition The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 + Details
Name: | us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAndCashAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration